Therapeutic potential of Zanha africana (Radlk.) Exell: antimycobacterial activity and safety evaluation

Zanha africana (Radlk.) Exell extracts are commonly utilized in Tanzania and other countries for treating conditions associated with HIV and AIDS, including tuberculosis (TB). In Tanzania, it is listed among the most frequently traded plant species for medicinal use in different marketplaces. However, limited literature exists regarding its antimycobacterial properties and safety profile. This study aimed to evaluate Z. africana ethanolic extract for safety and antimycobacterial activity. The antimycobacterial activity of the crude extracts was assessed using the broth microdilution method against various non-pathogenic mycobacteria strains including Mycobacterium aurum (MA) , Mycobacterium madagascariense (MM), and Mycobacterium indicus pranii (MIP). Bioassay-guided fractionation was employed to isolate the active compounds. The safety profile of the crude extract was investigated through cytotoxicity assay on peripheral blood mononuclear cells (PBMCs) and the brine shrimp lethality test. The 80% ethanolic extracts of Z. africana demonstrated activity against all tested non-pathogenic mycobacteria. The antimycobacterial activity of ethanolic extract of the stem bark was 625 µg/mL, 313 µg/mL and 125 µg/mL against MA, MM, and MIP, respectively. The most potent fraction was the ethyl acetate fraction, from which two active compounds were isolated: proanthocyanidin A 2 ; Compound ( 1 ) and its monomer epicatechin, Compound ( 2 ). Compound ( 1 ) exhibited higher antimycobacterial activity compared to compound (2 ) with minimum inhibitory concentrations (MICs) of 19.50 µg/mL and 12.98 µg/mL against MM and MIP respectively. The ethanolic extract did not demonstrate toxicity on PBMCs and brine shrimps. This study demonstrates that Z. africana extracts and the isolated compounds possess antimycobacterial activity. This provides evidence supporting the traditional use of Z. africana extracts for TB management. Further research is recommended to comprehensively evaluate the efficacy and safety of the plant constituents using different models.

Authors

Institutions

Publication Details

Journal
Scientific African
Published
2024-09-19
DOI
https://doi.org/10.1016/j.sciaf.2024.e02371
Citations
1
Primary Topic
Moringa oleifera research and applications
Type
article
Field-Weighted Citation Impact
0.60
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic potential of Zanha africana (Radlk.) Exell: antimycobacterial activity and safety evaluation

Alfredi A. Moyo, Matobola Joel Mihale, Joseph Sempombe, Ramadhani S.O. Nondo et al.
1 citations
Scientific African
Moringa oleifera research and applications
0.60
article

Therapeutic potential of Zanha africana (Radlk.) Exell: antimycobacterial activity and safety evaluation

Alfredi A. Moyo, Matobola Joel Mihale, Joseph Sempombe, Ramadhani S.O. Nondo, Paul Malaba, Rogers Mwakalukwa, Matthias Heydenreich, Alphonce Ignace Marealle, Michael Qwarse, Mainen J. Moshi, Francis Machumi, Alex John Bulashi
article en
1 citations

Abstract

Zanha africana (Radlk.) Exell extracts are commonly utilized in Tanzania and other countries for treating conditions associated with HIV and AIDS, including tuberculosis (TB). In Tanzania, it is listed among the most frequently traded plant species for medicinal use in different marketplaces. However, limited literature exists regarding its antimycobacterial properties and safety profile. This study aimed to evaluate Z. africana ethanolic extract for safety and antimycobacterial activity. The antimycobacterial activity of the crude extracts was assessed using the broth microdilution method against various non-pathogenic mycobacteria strains including Mycobacterium aurum (MA) , Mycobacterium madagascariense (MM), and Mycobacterium indicus pranii (MIP). Bioassay-guided fractionation was employed to isolate the active compounds. The safety profile of the crude extract was investigated through cytotoxicity assay on peripheral blood mononuclear cells (PBMCs) and the brine shrimp lethality test. The 80% ethanolic extracts of Z. africana demonstrated activity against all tested non-pathogenic mycobacteria. The antimycobacterial activity of ethanolic extract of the stem bark was 625 µg/mL, 313 µg/mL and 125 µg/mL against MA, MM, and MIP, respectively. The most potent fraction was the ethyl acetate fraction, from which two active compounds were isolated: proanthocyanidin A 2 ; Compound ( 1 ) and its monomer epicatechin, Compound ( 2 ). Compound ( 1 ) exhibited higher antimycobacterial activity compared to compound (2 ) with minimum inhibitory concentrations (MICs) of 19.50 µg/mL and 12.98 µg/mL against MM and MIP respectively. The ethanolic extract did not demonstrate toxicity on PBMCs and brine shrimps. This study demonstrates that Z. africana extracts and the isolated compounds possess antimycobacterial activity. This provides evidence supporting the traditional use of Z. africana extracts for TB management. Further research is recommended to comprehensively evaluate the efficacy and safety of the plant constituents using different models.

Scientific AfricanVol. 26
Muhimbili University of Health and Allied Sciences (TZ), University of Potsdam (DE), National Institute for Medical Research (TZ), Open University of Tanzania (TZ), Hubert Kairuki Memorial University (TZ)
Good health and well-being
Openalex Percentile: Top 22%
Moringa oleifera research and applications
0.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.